Seres Therapeutics, Inc. - Common Stock (MCRB)
7.1400
-1.1500 (-13.87%)
NASDAQ · Last Trade: May 8th, 2:45 PM EDT
Via Benzinga · May 8, 2025
Via Benzinga · May 8, 2025
Via Benzinga · April 22, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · April 15, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 14, 2025
Via Benzinga · April 14, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 12, 2025
Via Benzinga · March 12, 2025

Via Benzinga · January 16, 2025

Via Benzinga · October 24, 2024

Via Benzinga · September 26, 2024

MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024

Via Benzinga · June 7, 2024

MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 8, 2024

Via Benzinga · May 8, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · March 6, 2024